Investitionsbank des Landes Brandenburg
Investitionsbank des Landes Brandenburg, established in 1992 and headquartered in Potsdam, Germany, serves as a regional development bank focused on financing public and private investment projects across various sectors in Brandenburg. It offers a diverse range of funding programs, including grants and low-interest loans, aimed at supporting commercial enterprises, entrepreneurs, freelancers, and sectors such as agriculture and media. The bank also finances infrastructure initiatives for municipalities and local authorities, as well as projects in social, scientific, educational, and cultural domains. Additionally, it provides financial support for municipal, cooperative, and private housing projects, promoting residential development within the state. As a subsidiary of NRW.BANK, Investitionsbank des Landes Brandenburg operates under a legal framework that enables it to utilize state guarantees in compliance with European Union regulations.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Self-improvement
HelloBetter
Grant in 2024
HelloBetter is a digital therapeutics company that develops and delivers evidence‑based online mental‑health programs. Founded in 2015 as a university spin‑off, it offers courses for conditions such as stress, depression, anxiety, panic, insomnia, chronic pain, alcohol use, and diabetes‑related mood disorders. The platform is approved as a DiGA in Germany, allowing prescription‑based access and nationwide reimbursement for more than 73 million people. Over 30 randomized controlled trials have evaluated its ten programs, making it a global leader in digital mental‑health research. The company operates from Hamburg and Berlin and continues to expand beyond the DACH region.
HelloBetter
Debt Financing in 2024
HelloBetter is a digital therapeutics company that develops and delivers evidence‑based online mental‑health programs. Founded in 2015 as a university spin‑off, it offers courses for conditions such as stress, depression, anxiety, panic, insomnia, chronic pain, alcohol use, and diabetes‑related mood disorders. The platform is approved as a DiGA in Germany, allowing prescription‑based access and nationwide reimbursement for more than 73 million people. Over 30 randomized controlled trials have evaluated its ten programs, making it a global leader in digital mental‑health research. The company operates from Hamburg and Berlin and continues to expand beyond the DACH region.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.